Daiwa Securities Group Inc. Sells 5,275 Shares of Globe Life Inc. $GL

Daiwa Securities Group Inc. lessened its stake in Globe Life Inc. (NYSE:GL) by 43.3% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 6,918 shares of the company’s stock after selling 5,275 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Globe Life were worth $1,236,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in GL. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life during the second quarter worth approximately $28,000. Hilton Head Capital Partners LLC purchased a new position in Globe Life during the 4th quarter worth $30,000. MUFG Securities EMEA plc bought a new stake in Globe Life during the 2nd quarter valued at $31,000. Torren Management LLC purchased a new stake in shares of Globe Life in the 4th quarter worth $37,000. Finally, AdvisorNet Financial Inc grew its position in shares of Globe Life by 41.1% during the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock worth $44,000 after buying an additional 92 shares in the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on GL shares. TD Cowen upped their price objective on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. JPMorgan Chase & Co. boosted their price target on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Piper Sandler increased their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th. Finally, Jefferies Financial Group boosted their price objective on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $191.67.

Globe Life Stock Performance

GL stock opened at $180.87 on Friday. Globe Life Inc. has a one year low of $127.85 and a one year high of $191.55. The firm has a market cap of $13.90 billion, a price-to-earnings ratio of 12.01 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. The firm has a 50-day simple moving average of $177.16 and a two-hundred day simple moving average of $157.27.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities analysts forecast that Globe Life Inc. will post 15.71 EPS for the current fiscal year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s payout ratio is currently 8.76%.

Globe Life declared that its Board of Directors has approved a stock buyback plan on Monday, August 10th that authorizes the company to repurchase $2.50 billion in shares. This repurchase authorization authorizes the company to repurchase up to 17.7% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling at Globe Life

In other news, CEO Frank M. Svoboda sold 20,000 shares of the stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer owned 54,020 shares in the company, valued at approximately $8,463,853.60. This represents a 27.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 25,650 shares of the firm’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total value of $4,580,577.00. Following the completion of the sale, the chief financial officer directly owned 50,568 shares of the company’s stock, valued at $9,030,433.44. The trade was a 33.65% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 191,747 shares of company stock valued at $33,480,408. Corporate insiders own 2.11% of the company’s stock.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.